Category
October 18, 2017
Genomic Vision (Paris:GV) (Euronext: FR0011799907 – GV), a company specialized in the development of diagnostic tests for the early detection of cancers and genetic diseases, today reports of its second R&D Day which took place on October 16 in Paris and was attended by clients, investors, analysts, and journalists. This second edition was aimed at […]
October 18, 2017
October 9, 2017
Kennedie Bailey celebrated her 11th birthday in May with a sleepover, but she can’t remember much about the details because, shortly after, she was shocked to learn that she had a rare cancer. Aggressive rhabdomyosarcoma develops from connective tissues in the body, including muscles, bones, joints, and fat. It’s not uncommon for it to recur after […]
October 5, 2017
Pediatric Blood and Cancer: Electrophysiological effects of anthracyclines in adult survivors of pediatric malignancy. Researchers at Johns Hopkins Hospital conducted a retrospective chart review of 147 survivors of childhood cancer that were now over the age of 18. The goal of the study was to evaluate the correlation between abnormalities in electrocardiographic changes and cardiac […]
October 5, 2017
Researchers from the Greehey Children’s Cancer Research Institute at UT Health San Antonio co-authored a paper published Sept. 26 in Science Signaling that looks at the reliability of a common research tool to study RAS cancer mutations. RAS mutations are implicated in several cancers, including lung, colorectal, and pancreatic ductal carcinoma. The three RAS genes are the […]
October 4, 2017
October 4, 2017
“Dr. Peter Houghton, Director of the Greehey Children’s Cancer Research Institute at The University of Texas Health Science Center at San Antonio, discusses CPRIT and childhood cancer research.” Houghton Lab
September 28, 2017
Researchers from the Greehey Children’s Cancer Research Institute at UT Health San Antonio are co-authors on a paper published Sept. 26 in Science Signaling, a high-impact journal that is part of the Science family of journals. RAS mutations are implicated in several cancers, including lung, colorectal and pancreatic ductal carcinoma. The three RAS genes are the most frequently mutated […]
September 25, 2017
More than 15,000 children and adolescents up to 19 years old will receive a cancer diagnosis this year, according to the National Cancer Institute. After accidents, cancer is the second leading cause of death in children ages 1 to 14. Conditions most commonly affecting children include leukemia, lymphoma, and tumors affecting the bones or neural systems.
September 24, 2017
September is Childhood Cancer Awareness Month. Many citizens in our community may not realize that San Antonio is home to the Greehey Children’s Cancer Research Institute — the largest freestanding pediatric cancer research facility in Texas and one of the few research institutes worldwide devoted exclusively to childhood cancer. During this important month for childhood […]